This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Dat Ngo, PharmD
Advertisement
Articles by Dat Ngo, PharmD
USP 800 was a necessary step to maximize safety, but it also recommended many institutions reevaluate their facilities, equipment, processes, and staffing capacity, potentially costing millions of dollars.
Advertisement
Latest Updated Articles
The Impact of USP 797, USP 800 on Compounding PharmaciesApril 22nd 2022
Advertisement
Advertisement
Trending on Pharmacy Times
1
Anticoagulation in AFib: Risk Stratification, Therapy Selection, and Factor XI Inhibitors
2
ATTR-CM Red Flags, Treatment Evidence, and the Pharmacist's Role in Care
3
A Paradigm Shift in Lipid Management: Highlights from the NLA 2026 Scientific Sessions Opening Session
4
Vigilance in an Age of Misinformation: Rebuilding Trust Through Evidence and Connection
5